Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.9M Sell
3,973
-22
-0.6% -$35K 0.64% 39
2026
Q1
$5.28M Buy
3,995
+34
+0.9% +$46.6K 0.47% 49
2025
Q4
$4.24M Buy
3,961
+65
+2% +$67.8K 0.39% 62
2025
Q3
$3.77M Buy
3,896
+255
+7% +$200K 0.36% 67
2025
Q2
$2.92M Buy
3,641
+276
+8% +$198K 0.3% 74
2025
Q1
$2.23M Buy
3,365
+622
+23% +$452K 0.25% 83
2024
Q4
$1.9M Buy
2,743
+517
+23% +$371K 0.23% 79
2024
Q3
$1.85M Buy
2,226
+1,843
+481% +$1.65M 0.23% 76
2024
Q2
$392K Buy
383
+8
+2% +$7.69K 0.05% 146
2024
Q1
$364K Hold
375
0.05% 146
2023
Q4
$284K Hold
375
0.04% 147
2023
Q3
$218K Hold
375
0.04% 156
2023
Q2
$272K Buy
+375
New +$255K 0.05% 148

Other funds holding ASML

Allen Capital Group's ASML Position: Q2 2026 in Review

Allen Capital Group reduced its ASML (ASML) stake by 0.55% in Q2 2026, selling an estimated $35K and leaving 3,973 shares worth $7.9M. The position accounts for 0.64% of the portfolio, ranked #39.

Allen Capital Group first reported a position in ASML in Q2 2023 and has held it in 13 quarters since. 849 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Allen Capital Group held 3,973 shares of ASML worth $7.9M as of Q2 2026.
  • Allen Capital Group sold 22 ASML shares in Q2 2026, an estimated $35K.
  • ASML made up 0.64% of Allen Capital Group's portfolio in Q2 2026, its #39 holding.
  • Allen Capital Group first reported a position in ASML in Q2 2023 and has held it in 13 quarters since.
  • 849 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Allen Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.